EGM
ALXO icon

Engineers Gate Manager’s ALX Oncology ALXO Stock Holding History

Engineers Gate Manager’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,600
Closed -$76K – 2089
2024
Q2 		$76K Buy
+12,600
New +$155K ﹤0.01% 1773
2022
Q1 		– Sell
-10,700
Closed -$230K – 1818
2021
Q4 		$230K Buy
+10,700
New +$462K 0.01% 1559

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Engineers Gate Manager's ALXO Position: Q3 2024 in Review

Engineers Gate Manager sold out of ALX Oncology (ALXO) in Q3 2024, closing a stake of 12,600 shares — an estimated $76K sold.

Engineers Gate Manager first reported a position in ALXO in Q4 2021 and held it in 2 quarters. The position peaked at $230K in Q4 2021. 92 funds tracked by Wall St. Rank hold ALXO as of Q3 2024.

  • Engineers Gate Manager reported no remaining ALX Oncology position as of Q3 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 12,600 ALX Oncology shares in Q3 2024, an estimated $76K.
  • Engineers Gate Manager first reported a position in ALX Oncology in Q4 2021 and held it in 2 quarters.
  • Engineers Gate Manager's ALX Oncology position peaked at $230K in Q4 2021.
  • 92 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2024.

Based on Engineers Gate Manager's 13F filing for Q3 2024, filed 14 Nov 2024.